| Dr Aaron Michael Martin, DC | |
|
1710 W 1st St, Ankeny, IA 50023-2526 | |
| (515) 964-3000 | |
| (515) 964-3014 |
| Full Name | Dr Aaron Michael Martin |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 22 Years |
| Location | 1710 W 1st St, Ankeny, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154410843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 06497 (Iowa) | Primary |
| Provider Name | Iowa Chiropractic Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003960493 PECOS PAC ID: 3173699899 Enrollment ID: O20080904000066 |
News Archive
Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India.
The therapeutic potential of embryonic stem cells has been an intense focus of study and discussion in biomedical research and has resulted in technologies to produce human induced pluripotent stem cells (hiPSCs). Derived by epigenetic reprogramming of human fibroblasts, these hiPSCs are thought to be almost identical to human embryonic stem cells (hESCs) and provide great promise for patient-tailored regenerative medicine therapies.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
Royal Philips, a leader in integrated image-guided therapy solutions, today announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips is a pioneer in hybrid operating room (hybrid OR) solutions to facilitate both surgical and minimally-invasive endovascular procedures, with over 750 hybrid ORs installed globally. The addition of this new augmented reality technology will further widen the scope of Philips hybrid OR solutions to other fast-growing areas of image-guided surgery including spine, cranial and trauma procedures.
Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies.
› Verified 1 days ago
| Provider Name | Iowa Chiropractic Of Grimes Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124691266 PECOS PAC ID: 3577967512 Enrollment ID: O20210812001688 |
News Archive
Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India.
The therapeutic potential of embryonic stem cells has been an intense focus of study and discussion in biomedical research and has resulted in technologies to produce human induced pluripotent stem cells (hiPSCs). Derived by epigenetic reprogramming of human fibroblasts, these hiPSCs are thought to be almost identical to human embryonic stem cells (hESCs) and provide great promise for patient-tailored regenerative medicine therapies.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
Royal Philips, a leader in integrated image-guided therapy solutions, today announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips is a pioneer in hybrid operating room (hybrid OR) solutions to facilitate both surgical and minimally-invasive endovascular procedures, with over 750 hybrid ORs installed globally. The addition of this new augmented reality technology will further widen the scope of Philips hybrid OR solutions to other fast-growing areas of image-guided surgery including spine, cranial and trauma procedures.
Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Michael Martin, DC 1710 W 1st St, Ankeny, IA 50023-2526 Ph: (515) 964-3000 | Dr Aaron Michael Martin, DC 1710 W 1st St, Ankeny, IA 50023-2526 Ph: (515) 964-3000 |
News Archive
Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India.
The therapeutic potential of embryonic stem cells has been an intense focus of study and discussion in biomedical research and has resulted in technologies to produce human induced pluripotent stem cells (hiPSCs). Derived by epigenetic reprogramming of human fibroblasts, these hiPSCs are thought to be almost identical to human embryonic stem cells (hESCs) and provide great promise for patient-tailored regenerative medicine therapies.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
Royal Philips, a leader in integrated image-guided therapy solutions, today announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips is a pioneer in hybrid operating room (hybrid OR) solutions to facilitate both surgical and minimally-invasive endovascular procedures, with over 750 hybrid ORs installed globally. The addition of this new augmented reality technology will further widen the scope of Philips hybrid OR solutions to other fast-growing areas of image-guided surgery including spine, cranial and trauma procedures.
Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies.
› Verified 1 days ago
Iowa Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 1710 W 1st St, Ankeny, IA 50023 Phone: 515-964-3000 Fax: 515-964-3014 | |
Dr. Scott Ravn Andersen, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7302 Nw 19th St, Ankeny, IA 50023 Phone: 641-780-9634 | |
Dr. Rachel Ann Curtis, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 213 N Ankeny Blvd Ste 120, Ankeny, IA 50023 Phone: 515-964-7111 | |
Family Matters Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1210 Nw 18th St Ste 110, Ankeny, IA 50023 Phone: 515-630-0158 | |
Dr. Kevin J Stapleford, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 629 S Ankeny Blvd, Ankeny, IA 50023 Phone: 515-964-8547 Fax: 515-964-8563 | |
Mr. Brandon Kyle Boston, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 520 Sw 3rd St Suite 1b, Ankeny, IA 50023 Phone: 515-868-0320 | |
Brookfield Family Chiropractic P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2005 S Ankeny Blvd, Suite 600, Ankeny, IA 50023 Phone: 515-963-3999 Fax: 515-963-9716 |